IRBs gone wild

The trial was paid for by AstraZeneca, the maker of Seroquel XR, and was conducted by Dr. S. Charles Schulz, the head of psychiatry at the University of Minnesota. Two of the study participants were living in a residential treatment facility for sex offenders and may have lied about their diagnosis to qualify for the trial. One of those men slipped the drugs to unwitting treatment center residents and staff, an alarming development that nevertheless did not seem to ruffle the university oversight board that is charged with looking into such episodes.

http://www.nytimes.com/2015/04/19/business/seroquel-xr-drug-trial-frayed-promise.html?hp&action=click&pgtype=Homepage&module=second-column-regionĀ®ion=top-news&WT.nav=top-news&_r=0

Share